<DOC>
	<DOCNO>NCT02434172</DOCNO>
	<brief_summary>The study determine initiation 'screen treat ' program cryptococcal disease among HIV positive individual decrease morbidity mortality among individual CD4 count &lt; 100 cells/mm3 . The study screen individual asymptomatic CM either ART naïve ART experience CD4 count &lt; 100 cells/mm3 . The introduction cheap , easy use point care diagnostic test lateral flow assay facilitate rapid diagnosis cryptococcal disease resource limit setting . The investigator determine efficacy lateral flow assay identify latent asymptomatic cryptococcal disease . The investigator determine efficacy test detect disease readily available body fluid urine whole blood obtain via finger-stick method . The investigator also determine cost effectiveness screen treat approach cryptococcal disease Zimbabwe . The investigator also wish understand individual low CD4 count reactivate cryptococcal disease screen positive cryptococcal antigen ( CrAg ) others similar level immunocompromised .</brief_summary>
	<brief_title>CryptoART Study : Decreasing Mortality Associated With Initiation Antiretroviral Therapy Sub-Saharan Africa</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<criteria>Documented HIV positive test standard national algorithm CD4 count ≤100 cells/mm3 Age &gt; 18 year Residence within 50 km Harare Able provide write informed consent Presence clinical symptom suggestive meningitis . Recent history CM within 2 week enrollment , i.e. , participant within induction phase therapy . Individuals severe hepatic injury , jaundice , alanine transferase ( ALT ) &gt; 5x upper limit normal Individuals renal failure , define estimate Glomerular filtration rate ( eGFR ) ≤30 mL/min ( use MDRD ( Modification Diet Renal Disease ) equation ) Currently know pregnant A negative urine pregnancy test require study entry woman childbearing potential . The use contraception recommend woman childbearing potential high dose fluconazole therapy . Referral family planning service give necessary . Previous allergy reaction amphotericin B and/or fluconazole Currently enrol another clinical trial/study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Cryptococcus</keyword>
	<keyword>Lateral Flow Assay</keyword>
	<keyword>sub-Saharan Africa</keyword>
	<keyword>Screening</keyword>
	<keyword>treatment</keyword>
	<keyword>cryptococcal meningitis</keyword>
</DOC>